Status:
NOT_YET_RECRUITING
Effect of Enzymatic-Containing Mouth Spray (Oral7®) on Xerostomia Symptoms, Salivary Flow Rate, and Oral Health-Related Quality of Life in Older Patients
Lead Sponsor:
ZAINAB MAT YUDIN
Conditions:
Xerostomia
Geriatric
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Background: Xerostomia, or dry mouth, is a prevalent condition among older adults and has significant implications for oral and systemic health. It is associated with impaired chewing, swallowing, and...
Eligibility Criteria
Inclusion
- Aged 60 years and above
- Patients with often or always having dry mouth/xerostomia by asking single-item xerostomia question: "How often does your mouth feel dry?" (Adakah mulut anda sering merasakan kekeringan?). The response options were "Never (Tidak Pernah)," "Sometimes (Kadang-kadang)," "Often (Kerap)," or "Always (Sentiasa/Sepanjang masa)."
- Patients who are taking nutrition orally
- Patients who are able to speak
- Patients who are physically fit to take oral spray on their own.
Exclusion
- • Patients on salivary substitutes for the past one week
- Oral condition that required immediate attention such as mucosal or gingival bleeding, orofacial swelling, oral pain and oral ulcer.
- Patients who are deaf and mute
- Those with mental disabilities or documented cognitive deficits that would impair their ability to answer questions independently.
Key Trial Info
Start Date :
August 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06984848
Start Date
August 1 2025
End Date
December 1 2026
Last Update
May 29 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.